DAB2IP and breast carcinoma: The Prediction Analysis of Microarray 50–based (PAM50-based) risk of recurrence (ROR) score (Supplemental Table 1) is an established predictor of 10-year distant recurrence in patients with breast cancer (10, 11); therefore, we analyzed the ROR-Proliferation score (ROR-P) between DAB2IP-high and DAB2IP-low expression groups for each breast tumor subtype.